Dopavision
PrivateLast Round
Series A
Jul 14, 2021
Total Funding Raised
$17.19M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Dopavision operates in Healthcare & Life Sciences and is based in Berlin. Its latest recorded funding round was a Series A round in July 2021.
Dopavision is a biotechnology company that develops digital therapeutics for the management of myopia in children and adolescents.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Patient Engagement
Business Model
B2B2C
Customer Profile
Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dopavision Comparables
Compare Dopavision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eyerising International | 84% | |
| NovaSight | 82% | |
| Luminopia, Inc. | 80% |
For institutional investors. Book with your work email.
Dopavision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 14, 2021 | ||||
| Seed | May 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Dopavision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim Venture Fund | Series A, Seed |
| Seventure Partners | Series A |
| Flying Health | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 218% MoM, reaching 1.6K.
- Jul 25, 2026
Monthly visitors grew 160% MoM.
For institutional investors. Book with your work email.
Dopavision Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dopavision's valuation, stock price, and market status.
Is Dopavision a public or private company?
Dopavision is a private company.
What is the current stock price of Dopavision?
Dopavision is a private company, so its shares have no public market price. Caplight tracks Dopavision's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dopavision worth (valuation)?
Valuation information for Dopavision is not publicly available.
Can I buy Dopavision stock?
Dopavision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dopavision's last funding round?
Dopavision's most recent funding round was Series A on July 14, 2021.
Who are the main investors in Dopavision?
Key investors in Dopavision include Boehringer Ingelheim Venture Fund, Seventure Partners.
Will Dopavision IPO soon?
No public IPO plans have been announced for Dopavision.
How can I track Dopavision secondary market activity?
Caplight tracks bids, offers, and trades in Dopavision's shares on secondary markets.